ID

32344

Description

Study ID: 109563 Clinical Study ID: 109563 Study Title: COMPAS:A phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier https://clinicaltrials.gov/ct2/show/NCT00466947 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) Trade Name: BIO 10PN-PD-DIT; Synflorix Study Indication: Infections, Streptococcal The Study consists of three workbooks. Workbook 1: Argentina, all subjects + immuno & reacto subset Workbook 2: Panama, all subjects + immuno & reacto subset + carriage subset + additional immuno subset Workbook 3: Colombia, all subjects The protocol number for all workbooks: 109563 (10Pn-PD-DiT-028) There are ten visits in workbook 1 and 2, eight for workbook 3 (there are no visits 4 and 7): Visit 1: month 0, dose 1, 6-16 weeks of age Visit 2: month 2, dose 2, +/- 4 months of age, 49-83 days after visit 1 Visit 3: month 4, dose 3, +/- 6 months of age, 49-83 days after visit 2 Visit 4: month 5, +/- 7 months of age, 28-42 days after visit 3. Only for immuno & reacto subset + carriage subset. Visit 5: month 10-13, 12-15 months of age Visit 6: month 13-16, booster dose, 15-18 months of age, ≥ 28 days after visit 5 Visit 7: month 14-17, 16-19 months of age, 28-42 days after visit 6. Only for immuno & reacto subset, additional immuno subset + carriage subset. Visit 8: month 16-19, 18-21 months of age, ≥ 28 days after visit 6 Visit 9: month 22-25, 24-27 months of age Visit 10: Contact This document contains the non-serious adverse events form. It has to be filled in if non-serious adverse event occurs during study. It's for all workbooks.

Lien

https://clinicaltrials.gov/ct2/show/NCT00466947

Mots-clés

Versions (3)
  1. 26/10/2018 26/10/2018 -
  2. 27/10/2018 27/10/2018 -
  3. 27/10/2018 27/10/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

27 octobre 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Vaccination against pneumonia and otitis media, NCT00466947

Anglais

Non-serious adverse events

1 Formulaires  
Administrative data
Description

Administrative data

Alias
UMLS CUI-1
C1320722
Subject number
Description

Subject number

Type de données

text

Alias
UMLS CUI [1]
C2348585
Workbook number
Description

Workbook number

Type de données

integer

Alias
UMLS CUI [1]
C2986015
Date of non-serious adverse event
Description

Date of non-serious adverse event

Type de données

date

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0011008
Case number
Description

Case number

Type de données

integer

Alias
UMLS CUI [1,1]
C1698493
UMLS CUI [1,2]
C0600091
NON-SERIOUS ADVERSE EVENTS
Description

NON-SERIOUS ADVERSE EVENTS

Alias
UMLS CUI-1
C1518404
Has any non-serious adverse event leading to a non-administration of the vaccine or a visit/contact not done or a withdrawn?
Description

If you tick yes, please complete the following items.

Type de données

boolean

Alias
UMLS CUI [1]
C1518404
UMLS CUI [2,1]
C1298908
UMLS CUI [2,2]
C2368628
UMLS CUI [3,1]
C0545082
UMLS CUI [3,2]
C1272696
AE Number
Description

AE Number

Alias
UMLS CUI-1
C1518404
UMLS CUI-2
C0237753
AE Number
Description

AE Number

Type de données

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0237753
Description of AE
Description

Description of AE

Type de données

text

Alias
UMLS CUI [1,1]
C0678257
UMLS CUI [1,2]
C1518404
Site/Location of Adverse event
Description

Site/Location of Adverse event

Type de données

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0450429
Date Started
Description

Date Started

Type de données

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C1518404
Date started: during immediate post-vaccination period (30 minutes)
Description

Date started: post-vaccination periode

Type de données

boolean

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C1518404
UMLS CUI [1,3]
C0231291
Date Stopped
Description

Date Stopped

Type de données

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C1518404
Maximum Intensity
Description

Maximum Intensity

Type de données

integer

Alias
UMLS CUI [1,1]
C0518690
UMLS CUI [1,2]
C1518404
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
Description

Relationship to investigational products

Type de données

text

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C0085978
UMLS CUI [1,3]
C0304229
Outcome of AE
Description

Outcome of AE

Type de données

integer

Alias
UMLS CUI [1,1]
C1518404
UMLS CUI [1,2]
C1624730
Medically attended visit
Description

If yes please specify type in following item.

Type de données

text

Alias
UMLS CUI [1,1]
C0545082
UMLS CUI [1,2]
C1386497
Type of medically attended visit
Description

Type of medically attended visit

Type de données

text

Alias
UMLS CUI [1,1]
C0545082
UMLS CUI [1,2]
C1386497
UMLS CUI [1,3]
C0332307
Comment for GSK
Description

Comment for GSK

Type de données

text

Alias
UMLS CUI [1,1]
C0947611
UMLS CUI [1,2]
C0008961
Retour au début de la page

Similar models

Non-serious adverse events

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Administrative data
C1320722 (UMLS CUI-1)
Subject number
Item
Subject number
text
C2348585 (UMLS CUI [1])
Item
Workbook number
integer
C2986015 (UMLS CUI [1])
Workbook number
Code List
Workbook number
CL Item
workbook 1 (1)
CL Item
workbook 2 (2)
CL Item
workbook 3 (3)
Date of non-serious adverse event
Item
Date of non-serious adverse event
date
C1518404 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Case number
Item
Case number
integer
C1698493 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Item Group
NON-SERIOUS ADVERSE EVENTS
C1518404 (UMLS CUI-1)
Non-serious adverse event leading to non-administration of vaccine, visit/contact not done
Item
Has any non-serious adverse event leading to a non-administration of the vaccine or a visit/contact not done or a withdrawn?
boolean
C1518404 (UMLS CUI [1])
C1298908 (UMLS CUI [2,1])
C2368628 (UMLS CUI [2,2])
C0545082 (UMLS CUI [3,1])
C1272696 (UMLS CUI [3,2])
Item Group
AE Number
C1518404 (UMLS CUI-1)
C0237753 (UMLS CUI-2)
Item
AE Number
integer
C1518404 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
AE Number
Code List
AE Number
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
Description of AE
Item
Description of AE
text
C0678257 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Item
Site/Location of Adverse event
integer
C0877248 (UMLS CUI [1,1])
C0450429 (UMLS CUI [1,2])
Administration sites
Code List
Site/Location of Adverse event
CL Item
10Pn-PD-DiT vaccine / HBV Vaccine administration site (1)
CL Item
10Pn-PD-DiT vaccine / HAV Vaccine administration site (2)
CL Item
DTPa-IPV/Hib vaccine / Infanrix Hexa administration site (3)
CL Item
Non-administration site (4)
Date Started
Item
Date Started
date
C0808070 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Date started: post-vaccination periode
Item
Date started: during immediate post-vaccination period (30 minutes)
boolean
C0808070 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
C0231291 (UMLS CUI [1,3])
Date Stopped
Item
Date Stopped
date
C0806020 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Item
Maximum Intensity
integer
C0518690 (UMLS CUI [1,1])
C1518404 (UMLS CUI [1,2])
Maximum Intensity
Code List
Maximum Intensity
CL Item
Mild (1)
CL Item
Moderate (2)
CL Item
Severe (3)
Item
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
text
C1518404 (UMLS CUI [1,1])
C0085978 (UMLS CUI [1,2])
C0304229 (UMLS CUI [1,3])
Relationship to investigational products
Code List
Relationship to investigational products: Is there a reasonable possibility that the AE may have been caused by the investigational product?
CL Item
Yes (Y)
CL Item
No (N)
Item
Outcome of AE
integer
C1518404 (UMLS CUI [1,1])
C1624730 (UMLS CUI [1,2])
Outcome of AE
Code List
Outcome of AE
CL Item
Recovered / resolved (1)
CL Item
Recovering / resolving (2)
CL Item
Not recovered / not resolved (3)
CL Item
Recovered with sequelae / resolved with sequelae (4)
Item
Medically attended visit
text
C0545082 (UMLS CUI [1,1])
C1386497 (UMLS CUI [1,2])
Medically attended visit
Code List
Medically attended visit
CL Item
Yes (Y)
CL Item
No (N)
Item
Type of medically attended visit
text
C0545082 (UMLS CUI [1,1])
C1386497 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
Tpe of medically attended visit
Code List
Type of medically attended visit
CL Item
Hospitalisation (HO)
CL Item
Emergency Room (ER)
CL Item
Medical Personnel (MD)
Comment for GSK
Item
Comment for GSK
text
C0947611 (UMLS CUI [1,1])
C0008961 (UMLS CUI [1,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial